Viewing Study NCT05199103


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-05-29 @ 12:04 PM
Study NCT ID: NCT05199103
Status: UNKNOWN
Last Update Posted: 2022-01-20
First Post: 2021-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy
Sponsor: Medical University of Silesia
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graves Orbitopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Graves disease View
None proptosis View
None antithymocyte globulin View